Literature DB >> 15598560

Synthesis of imidazo[1,5,4-de]quinoxalin-9-ones, benzimidazole analogues of pyrroloiminoquinone marine natural products.

Daniel V Labarbera1, Edward B Skibo.   

Abstract

The imidazoquinoxalinones 1 and 2 are benzimidazole analogues of indole-based marine natural products called makaluvamins. The stabilized cation 1 and the zwitterion 2 were prepared in approximately 9 steps from readily available starting materials. Compound 1 is more cytostatic and cytotoxic than 2 and also shows activity in the hollow fiber assay. Unlike the indole-based natural products, 1 and 2 are not potent topoisomerase II inhibitors. Their pattern of cytotoxic and cyostatic activity could be related to inhibition of protein tyrosine kinases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15598560     DOI: 10.1016/j.bmc.2004.10.016

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  4 in total

1.  Correlative effect between in vivo hollow fiber assay and xenografts assay in drug screening.

Authors:  Keyong Ho Lee; Ki Hyeong Rhee
Journal:  Cancer Res Treat       Date:  2005-06-30       Impact factor: 4.679

2.  Pyrimido[1,2-a]benzimidazoles: synthesis and perspective of their pharmacological use.

Authors:  Victor V Fedotov; Vladimir L Rusinov; Evgeny N Ulomsky; Evgeny M Mukhin; Evgeny B Gorbunov; Oleg N Chupakhin
Journal:  Chem Heterocycl Compd (N Y)       Date:  2021-05-15       Impact factor: 1.490

3.  Sensing study of quinoxaline analogues with theoretical calculation, single-crystal X-ray structure and real application in commercial fruit juices.

Authors:  Shampa Chakraborty; Shyamaprosad Goswami; Ching Kheng Quah; Bholanath Pakhira
Journal:  R Soc Open Sci       Date:  2018-06-06       Impact factor: 2.963

Review 4.  A survey of marine natural compounds and their derivatives with anti-cancer activity reported in 2010.

Authors:  Marc Schumacher; Mareike Kelkel; Mario Dicato; Marc Diederich
Journal:  Molecules       Date:  2011-06-30       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.